Clinical & Experimental Ophthalmology (CEO)

Clinical & Experimental Ophthalmology is a leading international peer-reviewed medical journal dedicated to advancing knowledge in the field of eye health, vision science, and ophthalmic practice. As the official journal of the Royal Australian and New Zealand College of Ophthalmologists (RANZCO), it serves ophthalmologists, researchers, and clinicians worldwide by publishing high-quality original research articles, systematic reviews, clinical trials, case series, and expert analyses that span both clinical and experimental domains of ophthalmology. The journal’s scope encompasses broad topics such as ocular disease mechanisms, surgical innovations, pharmacological treatments, retinal research, glaucoma management, corneal pathology, ocular imaging, and translational research bridging basic science and clinical application. With rigorous peer review and a commitment to scientific excellence, the journal promotes interdisciplinary collaboration and evidence-based practice that can directly impact patient care and clinical outcomes. Its hybrid model supports both subscription access and optional open access publishing. With a strong emphasis on relevance and applicability to real-world ophthalmic practice, Clinical & Experimental Ophthalmology stands as a respected resource for clinicians, scientists, and trainees seeking the latest advances and insights in vision science and eye care.

Clinical & Experimental Ophthalmology (CEO) is :-

• International, Peer-Reviewed, Open Access, Refereed, Ophthalmology, clinical practice, research, experimental studies in eye diseases and vision science., surgical innovations, pharmacological treatments, retinal research, glaucoma management, corneal pathology, ocular imaging , Online or Print , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1442-6404, E-ISSN: 1442-9071, Established: 2000, Impact Factor: 5.6
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE